SMMT
#836
Summit Therapeutics Inc. - Common Stock
14.6 0 USD
+0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.11%
Changement Mensuel
+10.61%
Evolution sur 6 mois
-4.51%
Changement Annuel
-26.49%
Clôture Précédente
14.1 6
Open
14.6 0
Low
14.6 0
High
14.6 0
Volume
159
Financials
- Market Capitalization 11.65 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.13
ratio cours/chiffre d'affaires
-17.12 K
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 817 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 85.37 USD | +3.18% | -4.71% | -2.12% | +118.34% | 12.06 B USD | ||
| 821 |  CORT Corcept Therapeutics Incorporated - Common Stock | 110.43 USD | -2.60% | -7.40% | -2.27% | +50.51% | 11.94 B USD | ||
| 848 |  TECH Bio-Techne Corp - Common Stock | 72.30 USD | +0.17% | -0.11% | +0.25% | +35.93% | 11.34 B USD | ||
| 855 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 209.92 USD | +3.50% | +2.40% | -1.37% | +61.23% | 11.00 B USD |